Barorefiex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials

M. T. La Rovere, G. D. Pinna, S. H. Hohnloser, F. I. Marcus, A. Mortara, R. Nohara, Jr Bigger J.T., A. J. Camm, P. J. Schwartz

Research output: Contribution to journalArticle

557 Citations (Scopus)

Abstract

Background - The need for accurate risk stratification is heightened by the expanding indications for the implantable cardioverter defibrillator. The Multicenter Automatic Defibrillator Implantation Trial (MADIT) focused interest on patients with both depressed left ventricular ejection fraction (LVEF) and the presence of nonsustained ventricular tachycardia (NSVT). Meanwhile, the prospective study Autonomic Tone and Reflexes After Myocardial Infarction (ATRAMI) demonstrated that markers of reduced vagal activity, such as depressed baroreflex sensitivity (BRS) and heart rate variability (HRV), are strong predictors of cardiac mortality after myocardial infarction. Methods and Results - We analyzed 1071 ATRAMI patients after myocardial infarction who had data on LVEF, 24-hour ECG recording, and BRS. During follow-up (21±8 months), 43 patients experienced cardiac death, 5 patients had episodes of sustained VT, and 30 patients experienced sudden death and/or sustained VT. NSVT, depressed BRS, or HRV were all significantly and independently associated with increased mortality. The combination of all 3 risk factors increased the risk of death by 22×. Among patients with LVEF

Original languageEnglish
Pages (from-to)2072-2077
Number of pages6
JournalCirculation
Volume103
Issue number16
Publication statusPublished - Apr 24 2001

Fingerprint

Cardiac Arrhythmias
Heart Rate
Clinical Trials
Baroreflex
Myocardial Infarction
Stroke Volume
Ventricular Tachycardia
Reflex
Defibrillators
Mortality
Implantable Defibrillators
Sudden Death
Electrocardiography
Prospective Studies

Keywords

  • Arrhythmia
  • Autonomic
  • Baroreceptors
  • Heart rate
  • Myocardial infarction
  • Nervous system

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Barorefiex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias : Implications for clinical trials. / La Rovere, M. T.; Pinna, G. D.; Hohnloser, S. H.; Marcus, F. I.; Mortara, A.; Nohara, R.; Bigger J.T., Jr; Camm, A. J.; Schwartz, P. J.

In: Circulation, Vol. 103, No. 16, 24.04.2001, p. 2072-2077.

Research output: Contribution to journalArticle

@article{bc376fb3d5c64667a5d649a51b1f8972,
title = "Barorefiex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials",
abstract = "Background - The need for accurate risk stratification is heightened by the expanding indications for the implantable cardioverter defibrillator. The Multicenter Automatic Defibrillator Implantation Trial (MADIT) focused interest on patients with both depressed left ventricular ejection fraction (LVEF) and the presence of nonsustained ventricular tachycardia (NSVT). Meanwhile, the prospective study Autonomic Tone and Reflexes After Myocardial Infarction (ATRAMI) demonstrated that markers of reduced vagal activity, such as depressed baroreflex sensitivity (BRS) and heart rate variability (HRV), are strong predictors of cardiac mortality after myocardial infarction. Methods and Results - We analyzed 1071 ATRAMI patients after myocardial infarction who had data on LVEF, 24-hour ECG recording, and BRS. During follow-up (21±8 months), 43 patients experienced cardiac death, 5 patients had episodes of sustained VT, and 30 patients experienced sudden death and/or sustained VT. NSVT, depressed BRS, or HRV were all significantly and independently associated with increased mortality. The combination of all 3 risk factors increased the risk of death by 22×. Among patients with LVEF",
keywords = "Arrhythmia, Autonomic, Baroreceptors, Heart rate, Myocardial infarction, Nervous system",
author = "{La Rovere}, {M. T.} and Pinna, {G. D.} and Hohnloser, {S. H.} and Marcus, {F. I.} and A. Mortara and R. Nohara and {Bigger J.T.}, Jr and Camm, {A. J.} and Schwartz, {P. J.}",
year = "2001",
month = "4",
day = "24",
language = "English",
volume = "103",
pages = "2072--2077",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "16",

}

TY - JOUR

T1 - Barorefiex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias

T2 - Implications for clinical trials

AU - La Rovere, M. T.

AU - Pinna, G. D.

AU - Hohnloser, S. H.

AU - Marcus, F. I.

AU - Mortara, A.

AU - Nohara, R.

AU - Bigger J.T., Jr

AU - Camm, A. J.

AU - Schwartz, P. J.

PY - 2001/4/24

Y1 - 2001/4/24

N2 - Background - The need for accurate risk stratification is heightened by the expanding indications for the implantable cardioverter defibrillator. The Multicenter Automatic Defibrillator Implantation Trial (MADIT) focused interest on patients with both depressed left ventricular ejection fraction (LVEF) and the presence of nonsustained ventricular tachycardia (NSVT). Meanwhile, the prospective study Autonomic Tone and Reflexes After Myocardial Infarction (ATRAMI) demonstrated that markers of reduced vagal activity, such as depressed baroreflex sensitivity (BRS) and heart rate variability (HRV), are strong predictors of cardiac mortality after myocardial infarction. Methods and Results - We analyzed 1071 ATRAMI patients after myocardial infarction who had data on LVEF, 24-hour ECG recording, and BRS. During follow-up (21±8 months), 43 patients experienced cardiac death, 5 patients had episodes of sustained VT, and 30 patients experienced sudden death and/or sustained VT. NSVT, depressed BRS, or HRV were all significantly and independently associated with increased mortality. The combination of all 3 risk factors increased the risk of death by 22×. Among patients with LVEF

AB - Background - The need for accurate risk stratification is heightened by the expanding indications for the implantable cardioverter defibrillator. The Multicenter Automatic Defibrillator Implantation Trial (MADIT) focused interest on patients with both depressed left ventricular ejection fraction (LVEF) and the presence of nonsustained ventricular tachycardia (NSVT). Meanwhile, the prospective study Autonomic Tone and Reflexes After Myocardial Infarction (ATRAMI) demonstrated that markers of reduced vagal activity, such as depressed baroreflex sensitivity (BRS) and heart rate variability (HRV), are strong predictors of cardiac mortality after myocardial infarction. Methods and Results - We analyzed 1071 ATRAMI patients after myocardial infarction who had data on LVEF, 24-hour ECG recording, and BRS. During follow-up (21±8 months), 43 patients experienced cardiac death, 5 patients had episodes of sustained VT, and 30 patients experienced sudden death and/or sustained VT. NSVT, depressed BRS, or HRV were all significantly and independently associated with increased mortality. The combination of all 3 risk factors increased the risk of death by 22×. Among patients with LVEF

KW - Arrhythmia

KW - Autonomic

KW - Baroreceptors

KW - Heart rate

KW - Myocardial infarction

KW - Nervous system

UR - http://www.scopus.com/inward/record.url?scp=0035942099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035942099&partnerID=8YFLogxK

M3 - Article

C2 - 11319197

AN - SCOPUS:0035942099

VL - 103

SP - 2072

EP - 2077

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 16

ER -